1. 209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension. (April 2019) Authors: Morand, Eric; T Merrill, Joan; A Isenberg, David; H Kao, Amy; Vazquez-Mateo, Cristina; Wax, Stephen; Chang, Peter; Pudota, Kishore; Aranow, Cynthia; J Wallace, Daniel Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗